feed,title,long_url,short_url
Investors,BioMarin Bolsters Pipeline With $270 Million Inozyme Pharma Takeover,https://www.investors.com/news/technology/biomarin-inozyme-acquisition-enzyme-replacement-therapy-ert/,https://da.gd/YMlya
Investors,IBD 50 Stock Travere Therapeutics Nosedived On An FDA Decision â€” Here's Why,https://www.investors.com/news/technology/travere-therapeutics-filspari-fsgs-advisory-committee-meeting/,https://da.gd/DLLLU
